more time for patient care
TRANSCRIPT
MORE TIME FOR PATIENT CARE.
FREE UP CLINICAL TIME WITH SUPERIOR EFFICIENCY AND INNOVATIVE MONITORING SOLUTIONS7-23
Reveal LINQ™ Industry Leading ICM System
Out-of-lab Procedure
Reveal LINQ™ Mobile Manager
Unmatched Accuracy: AF False Positive Rate
Time Saved with Reveal LINQ™
TRUSTED TO DIAGNOSE
SUPERIOR EFFICIENCY
UNIQUE MONITORING SOLUTIONS
Proven Outcomes: Syncope
Stroke
Reveal LINQ™ ICM System
BeConnected Patient Service
FocusOn™ Monitoring and Triaging Service
3.6xMore likely to reach diagnosis with ICM vs. standard of care.1
€6,513Average cost per patient of recurrent syncope hospitalisations.2
THE REVEAL™ FAMILY OF ICMS HAS AN EVIDENCE PORTFOLIO THAT INCLUDES900+PUBLISHED CLINICALARTICLES AND ABSTRACTS.3
DELIVERINGPROVEN OUTCOMESTO ENABLETIMELY TREATMENT.
SYNCOPEEarlier use of the Reveal LINQ™ ICM increases diagnostic yield versus standard of care, whilst reducing hospitalizations, injuries, and costs associated with Syncope patients.1,2
ESC 2018 SYNCOPE GUIDELINES
COR* LOE*
I A
Highest recommendation and evidence for early ICM monitoring for patients with high arrhythmia risk or recurrent symptoms more than 30 days apart.1
*COR: Class of RecommendationLOE: Level of Evidence
TRUSTED TO DIAGNOSE
55%Decreased risk of recurrent stroke shown in patients who undergo prolonged cardiac monitoring vs conventional cardiac monitoring.5
STROKEReveal LINQ™ with TruRhythm™ enables higher AF detection and lower stroke recurrence associated with Stroke patients.5
In selected stroke patients without previously known AF, additional ECG monitoring using long-term non-invasive ECG monitors or insertable cardiac monitors should be considered, to detect AF.4
*COR: Class of RecommendationLOE: Level of Evidence
€43,129Direct healthcare cost of a stroke per patient.6
COR* LOE*
IIa B
ESC 2020 ATRIAL FIBRILLATION GUIDELINES
THE REVEAL™ FAMILY OF ICMS HAS AN EVIDENCE PORTFOLIO THAT INCLUDES900+PUBLISHED CLINICALARTICLES AND ABSTRACTS.3
DELIVERINGPROVEN OUTCOMESTO ENABLETIMELY TREATMENT.
TRUSTED TO DIAGNOSE
SUPERIOR EFFICIENCY
OPTIMIZING RESOURCESWITHOUT COMPROMISING SAFETY AT INSERTION.
SAFE
<1%COMPLICATIONS AND NO INFECTIONS OBSERVED18
TIME-SAVING UP TO
45MINUTES SHORTER PROCEDURE Vs. IN-LAB31
COST-SAVING
€400- €800SAVED PER PATIENT Vs. IN-LAB11
REVEAL LINQ™ OUT-OF-THE-LAB PROCEDURE· Frees up cath lab for essential procedures7,9,10,11
· Requires less specialized staff 7,8,9,10,11
· Improves patient flow/wait time7,11,12
Reveal LINQ™ has extensive evidence to support out-of–lab insertion being feasible, safe and efficient.7-18,31
ENABLING SEAMLESS OUT-OF-LAB PROCEDURE, WITH INTEGRATED DEVICE PROGRAMMING AND REMOTE MONITORING ENROLLMENT CAPABILITIES.
REVEAL LINQ™ MOBILE MANAGER
EXCLUSIVE APP-BASED PROGRAMMERTablet convenience for device programming & follow-up checks out-of-lab.
STREAMLINED DATA MANAGEMENTManage device registration, activation, and CareLink™ pre-enrollment, right from your tablet.
INTUITIVE WORKFLOWGuided workflow animations for device activations and follow-up guidance.
SUPERIOR EFFICIENCY
Disclaimer: A controlled, head-to-head study evaluating the comparative performance of these devices has not been done.*�Based�on�AF�episodes�≥�2�minutes�and�in�known�AF�patients.�%�of�false�positives�=�(1�–�episode�PPV).�AF�episodes�PPV�may�vary�between�gross�and�patient�average.†�Confirm™ Rx with SharpSense™ technology & BIOMONITOR III have no published clinical evidence showing AF episode PPV or AF sensitivity.
No Published Clinical Evidence
No Published Clinical Evidence
26.3%
39.9%
4.7%Confirm�Rx™
SharpSense™ †
2019
Confirm�Rx™20,21
2017
AF False positives %*
BIOMONITOR III™ †
2019
Reveal LINQ™
TruRhythm™ Detection19
2017
BioMonitor 222
2017
8xFewer False Positives 19-21
UNMATCHED ACCURACYLowest published rate of AF false episodes19-22
SIGNIFICANTLYREDUCING BURDEN ASSOCIATED WITH EPISODE REVIEW.
SUPERIOR EFFICIENCY
Review�time�of�11.3�minutes�per�transmission,�based�on�workflow�observation.�In�a�known�AF�patient�population.�%�Full-time�Employee�100�Patient�Clinic,�40�hours�per�week,�44�weeks/year
When compared to other ICMs, Reveal LINQ™ with TruRhythm™ Detection provides up to:19,23,30
36% REDUCTION IN STAFFING TIME
23% REDUCTION IN STAFFING TIME
21 WORKING DAYS SAVED PER CLINIC, PER YEAR
11 WORKING DAYS SAVED PER CLINIC, PER YEAR
Vs Confirm™ RX Vs BioMonitor™ 2
SIGNIFICANTLYREDUCING BURDEN ASSOCIATED WITH EPISODE REVIEW.
SUPERIOR EFFICIENCY
UNIQUE MONITORING SOLUTIONS
ENABLING BEST QUALITY OF CARE WHILST DRIVING EFFICIENCIES AT EVERY STEP OF THE PATH TO DIAGNOSIS.
Reveal LINQ™ ICM with TruRhythm™ Detection
MyCareLink™ Patient Monitor
BeConnected Patient Service
CareLink™ Network
FocusOn™ Monitoring and Triaging Service
Reveal LINQ™ Mobile Manager
REMOTE MONITORING SHORTENS THE TIME BETWEEN INSERTION AND DIAGNOSIS BY 7 MONTHS28
WHEN COMPARED TO CONVENTIONAL FOLLOW-UP.MOVE DATA, NOT PATIENTS.
Exclusive app-based programmer that simplifies ICM procedure, enabling device activation, programming and CareLink™ pre-enrollment, all from your tablet.
World’s smallest24 and most accurate25 ICM, enabling diagnosis even for the most difficult-to-detect arrhythmias.
Easy-to-use remote patient monitor with international coverage. Keeps you seamlessly connected to your patients.
Phone support service dedicated to patients. Frees up clinic time as patients can contact us when they have device or monitoring questions.
Patient monitoring network that enables data-driven care decisions, quickly and easily.
A support service for healthcare professionals that saves time and enables better outcomes by triaging all CareLink™ data and promptly alerting clinical teams to the 20% of data that requires action.26,27
FREEING UP CLINIC TIME WITH SERVICES THAT ENABLE EFFICIENT PATIENT MANAGEMENT.
HELPS PATIENTS WITH QUESTIONS ABOUT DEVICES & MONITORING
BECONNECTED PATIENT SERVICEBeConnected is a patient support service designed to free up clinic time by directing patients to our experienced team.
UNIQUE MONITORING SOLUTIONS
FOCUSON™ MONITORING AND TRIAGING SERVICEFocusOn™ operates as a virtual extension of your team. Staffed with certified ECG device specialists and cardiologists, FocusOn™ reduces time spent reviewing non-actionable data, so that hospital clinical teams can focus on what matters.
3xFASTER IN REVIEWING TRANSMISSIONS FROM RECEPTION, VS STANDARD HOSPITAL WORKFLOW27
<1 DAYTO ESCALATE URGENT EVENTS27
>3HOF DATA REVIEW IS SAVED PER PATIENT PER YEAR29,30
FREEING UP CLINIC TIME WITH SERVICES THAT ENABLE EFFICIENT PATIENT MANAGEMENT.
UNIQUE MONITORING SOLUTIONS
References
1. Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. June 1, 2018;39(21):1883-1948.
2. Wolff P. Long Term Clinical and Economic Burden of Recurrent Unexplained Syncope and the Real World Effectiveness of Insertable Cardiac Monitors in England. Presented at ESC 2016.
3. Medtronic Reveal™ Publications. Medtronic data on file. 2021.
4. Hindricks G, et al. “2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).” EurHeart J. 2020; 00:1-126.
5. Tsivgoulis G, et al. Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia. Stroke. Published online June 20, 2019.
6. Kolominsky-Rabas PL, Heuschmann PU, Marschall D, et al. Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry. Stroke. May 2006;37(5): 1179-1183.
7. Roebuck, A., et al. BJC 22 (2015).
8. BHRS Standards for insertion, follow up and explant of implantable loop recorders [ILRs] by non-medical staff, 2018.
9. Di Odoardo LAF, et al. J Cardiovasc Med. 2017;18:550-552.
10. Kipp R, et al.PACE. 2017;40:982-985.
11. Kanters, Tim A., et al. Europace (2015): euv217.
12. Wong GR, et al. Int J Cardiol. 2016;223:13-17.
13. Mittal S, et al. PACE. 2015; 38:1464-1469.
14. Beinart SC, et al. Heart Rhythm. 2016;13:5 SUPPL 1 (S15).
15. Sanders P, et al. JACC. 2017;69:354.
16. Diederichsen SZ, et al. Int J Cardiol. 2017;241:229-234.
17. Maines M et al. Europace. 2017;doi:10.1093/europace/eux187.
18. Rogers JD, et al. Heart Rhythm. 2017;14:218-224.
19. Pürerfellner H, et al. Europace. 2018;20:f321-f328.
20. Confirm Rx™ ICM DM3500 FDA Clearance Letter. 2017.
21. Nölker G, et al. J Cardiovasc Electrophysiol. 2016;27:1403-1410.
22. Biotronik BioMonitor 2 Technical Manual. 2017.
23. Rosemas S. AF Algorithm Clinic Efficiency. Medtronic data on file. April 2020. Based on Rogers J., et al. Circulation 140: A11947, Nölker 2016, Confirm Rx™ ICM DM3500 FDA Clearance Letter. 2017, Biotronik BioMonitor™ 2 Technical Manual 2017. Pürerfellner 2018.
24. ICM Size Comparison Guide. Medtronic data on file. 2021.
25. ICM Published Accuracy Comparison Guide. 2021.
26. Cronin et al, 2012, Heart Rhythm, vol 9, n°12.
27. Medtronic Data on File.
28. Drak-Hernández Y et al. Effectiveness and safety of remote monitoring of patients with an implantable loop recorder. Rev Esp Cardiol (Engl Ed). 2013;66(12):943-8.
29. Nicolle E, et al. Clinic time required to manage remote monitoring of cardiac implantable electronic devices: impact of outsourcing initial data review and triage. EP Europace. 2021;23(Supplement_3):euab116-519.
30. Seiler A, et al. Clinic time required for remote and in-person management of cardiac device patients: Time and motion workflow evaluation. JMIR Cardio (Forthcoming). doi:10.2196/27720.
31. Rogers, John D., et al. Journal of Medical Economics (2020): 1-8.
BRIEF STATEMENT See the device manual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events, If using an MRI SureScan™ device, see the MRI SureScan™ technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on www.manuals.medtronic.com. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.
Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. ™* Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Photo credit: Getty Images, Adobe Stock
Europe Medtronic International Trading Sàrl. Route du Molliau 31 Case postale CH-1131 Tolochenaz www.medtronic.eu Tel: +41 (0)21 802 70 00 Fax: +41 (0)21 802 79 00
United Kingdom/Ireland Medtronic Limited Building 9 Croxley Park Hatters Lane Watford Herts WD18 8WW www.medtronic.co.uk Tel: +44 (0)1923 212213 Fax: +44 (0)1923 241004
UC202102018bEE © Medtronic 2021. All rights reserved.
medtronic.eu